Previous 10 | Next 10 |
Aduro BioTech (NASDAQ: ADRO ) -10% after Novartis bails on Aduro's ADU-S100 . More news on: Aduro BioTech, Inc., ADDvantage Technologies Group, Inc., FedEx Corporation, Stocks on the move, Read more ...
Balance Sheet Strengthened to Support Pipeline Advancement and Oxbryta™ (voxelotor) Commercialization SOUTH SAN FRANCISCO, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it has entered into a $150 million loan ag...
Collaboration Combines GBT’s Therapeutic Area Leadership with Power of Syros’ Gene Control Platform to Find New Medicines to Induce Fetal Hemoglobin Syros to Receive $20 Million Upfront, Three Years of Preclinical Research Funding and Milestone Payments ...
The following list reflects actual dividend paying stocks that I hold in my personal portfolio: Barings BDC, Inc. ( BBDC ), BlackRock Capital Investment ( BKCC ), Blueknight Energy Partners - PFD Units ( BKEPP ), BlackRock Income Trust ( BKT ), BlackRock Enhanced Equity Dividend Trust ( BDJ ),...
Are there other aspects of the business, somewhat peculiar to the industry involved, which will give the investor important clues as to how outstanding the company may be in relation to its competition? - Philip Fisher One of the most exciting times for bioscience investors is during a p...
Image Source: The Economic Times Company Thesis Global Blood Therapeutics ( GBT ) is a mid-cap biotech company currently investigating potential drug candidates in hematology. The company's flagship product, Voxelotor, is an oral, once-daily therapy that modulates hemoglobin...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch t...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
The U.S. Food and Drug Administration's made it clear that granting a priority review to an application isn't exactly the same thing as making an application's review a top priority. Over the past five weeks, the agency stamped approvals on five new drugs months ahead of an already shortened sc...
Global Blood Therapeutics, Inc. ( GBT ) confirmed that the FDA has approved Oxbryta (voxelotor) tablets for the treatment of sickle cell disease in adults and children 12 years of age and older. According to the company press release , Oxbryta is the "first and only FDA-approved sickle hemo...
News, Short Squeeze, Breakout and More Instantly...
Global Blood Therapeutics Inc. Company Name:
GBT Stock Symbol:
NASDAQ Market:
Global Blood Therapeutics Inc. Website:
Guerbet to Spotlight the Novel New Drug Elucirem™ (gadopiclenol) injection at the 2022 Radiological Society of North America Scientific Assembly and Annual Meeting PR Newswire Join us at Booth #1711 Opportunity to learn about the recently US FDA-approved nov...
The healthcare industry is growing at an unprecedented rate, and healthcare stocks are poised to benefit from this growth. This is large because healthcare companies are developing innovative new treatments and technologies that are transforming the way we care for our health. As a resu...
NEW YORK, NY / ACCESSWIRE / September 22, 2022 / New York, New York-Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: EVO Payments...